We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
654 hedge funds and large institutions have $12.1B invested in State Street SPDR S&P Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 138 funds opening new positions, 233 increasing their positions, 170 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
318% more first-time investments, than exits
New positions opened: 138 | Existing positions closed: 33
55% more funds holding in top 10
Funds holding in top 10: 11 → 17 (+6)
37% more repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 170
35% more capital invested
Capital invested by funds: $8.96B → $12.1B (+$3.1B)
18% more funds holding
Funds holding: 554 → 654 (+100)
5.19% more ownership
Funds ownership: 171.15% → 176.34% (+5.2%)
80% less call options, than puts
Call options by funds: $883M | Put options by funds: $4.34B
Holders
654
Holders Change
+100
Holders Change %
+18.05%
% of All Funds
11.57%
Holding in Top 10
17
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+54.55%
% of All Funds
0.3%
New
138
Increased
233
Reduced
170
Closed
33
Calls
$883M
Puts
$4.34B
Net Calls
-$3.46B
Net Calls Change
-$1.53B
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$1.23B |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$570M |
| 3 |
Citigroup
New York
|
-$249M |
| 4 |
Barclays
London,
United Kingdom
|
-$238M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$224M |
